BrightSpring Health Services, Inc. (BTSGU) company profile
Close on Oct 30, 2026Market cap $13.24BP/E 36.4Yield –
About BrightSpring Health Services
Services-Home Health Care Services, SIC 8082
The company operates a home- and community-based healthcare services platform delivering integrated pharmacy and clinical care to medically complex senior and specialty patients. Its operations are divided into two primary segments: Pharmacy Solutions and Provider Services. Through Pharmacy Solutions, the company provides specialty, infusion, and community-based medication therapy management, dispensing oral, injectable, and intravenous medications to individuals with chronic or acute health conditions. Through Provider Services, the organization delivers home health care, hospice, home-based primary care, rehabilitation therapies such as physical, speech, occupational, and applied behavior analysis, and supportive personal care assisting with activities of daily living. Its customer base includes senior living communities, skilled nursing and rehabilitation facilities, hospitals, and patients covered by Medicare, Medicaid, and commercial health insurance.
The company delivers its care solutions across all 50 U.S. states, with co-located pharmacy and provider services in 40 states. Operations encompass more than 175 pharmacies, infusion centers, and specialty oncology sites, serving approximately 7,700 office, clinic, and client locations nationwide. The provided text does not identify the company's headquarters location.
Summary of the business section of BrightSpring Health Services's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BrightSpring Health Services, Inc.
- Headquarters
- Louisville, KY
- Address
- 805 N. Whittington Parkway 40222
- Phone
- (502) 394-2100
- Website
- brightspringhealth.com
- Employees
- 23,500, Dec 31, 2025
- Industry
- Services-Home Health Care Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Louisville, Kentucky
Stock & identifiers
- Ticker
- BTSGU
- Other tickers
- BTSG
- Exchange
- Nasdaq
- IPO date
- Jan 26, 2024
- Shares outstanding
- 198M, Jul 28, 2026
- Public float
- $2.35B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1865782
- CUSIP
- 10950A106
- ISIN
- US10950A1060
- EIN
- 82-2956404
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jon B. Rousseau | See Remarks, Director | 1,507,947 |
| Scott A. Greenwell | President, PharMerica | 46,345 |
| Lisa A. Nalley | See Remarks | 131,948 |
| Jennifer A. Phipps | Chief Financial Officer | 250,224 |
| Robert Allen Barnes | President, Community Living | 25,549 |
| Michael A. McMaude | See Remarks | 207,590 |
| Jennifer Yowler | President, PharMerica | 75,401 |
| James F. Mattingly Jr | See Remarks | 122,665 |
| Nigam H. Shah | Director | 4,013 |
| Steven B. Miller | Director | 23,106 |
| Olivia F. Kirtley | Director | 36,997 |
| Timothy A. Wicks | Director | 25,504 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $17.84M | $44.11M | $1.87M | $340 | $124 |
| FY2024 | $17.67M | $15.86M | $1.92M | $155 | $103 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Jon Rousseau President and Chief Executive Officer | $1.32M | – | $6.00M | $6.00M | $3.89M | $630.98K | $17.84M | +1% |
| Jim Mattingly Former Executive Vice President and Chief Financial Officer | $106.15K | – | – | – | – | $437.30K | $543.46K | -77% |
| Jennifer Phipps Executive Vice President and Chief Financial Officer | $469.27K | – | $1.50M | $1.50M | $927.08K | $47.70K | $4.44M | – |
| Bob Barnes President, Community Living | $450.02K | $187.50K | – | – | $430.65K | $1.77K | $1.07M | -39% |
| Lisa Nalley Chief of Staff and Senior Vice President, Human Resource | $349.68K | – | $800.01K | $800.00K | $445.00K | $1.57K | $2.40M | +5% |
| Scott Greenwell Executive Vice President and President, PharMerica | $249.04K | $274.00K | $375.01K | $375.01K | $162.97K | $738 | $1.44M | – |
| Jennifer Yowler Former President, PharMerica and Senior Vice President, Sales and Account Management | $440.00K | $5.00K | $400.01K | $400.00K | $104.76K | $1.75K | $1.35M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had over 23,500 full-time equivalent employees at the Company.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 31, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jan 26, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Jan 26, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |